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Abstract
Introduction This study aimed to (1) report the rates of resistance against a variety of antibiotics for pure Staphylococcal 
infections, and (2) examine the impact of ALBC use at primary surgery has on resistance patterns for patients undergoing 
first-time revision of primary hip and knee arthroplasty for indication of infection.
Materials and methods Data from the National Joint Registry database for England and Wales were linked to microbiology 
data held by Public Health England to identify a consecutive series of 258 primary hip and knee arthroplasties performed 
between April 2003 and January 2014 that went on to have a revision for Staphylococcal deep periprosthetic infection. Mul-
tivariate binary logistic regression was used to study predictors of microorganism resistance to a range of antimicrobials.
Results After adjusting for patient and surgical factors, multivariate analysis showed the use of gentamicin-loaded bone 
cement at the primary surgery was associated with a significant increase in the risk of Staphylococcal gentamicin resistance 
(odds ratio 8.341, 95% CI 2.297–30.292, p = 0.001) and methicillin resistance (odds ratio 3.870, 95% CI 1.319–11.359, 
p = 0.014) at revision for infection.
Conclusions Clinicians must anticipate the possibility of antibiotic resistance to ALBC utilised at primary surgery.
Keywords Arthroplasty · Revision · Infection · Sensitivity · Resistance · Staphylococcus
Introduction
Deep periprosthetic infection (PJI) following primary hip 
and knee arthroplasty is a catastrophic complication in 
terms of patient outcome and cost to the health service. The 
implicated microorganism(s) are important determinants 
of clinical outcome and previous work by our group has 
described the epidemiology in England and Wales by link-
ing data held by the national joint registry (NJR) to national 
microbiology data [11, 12].
In addition to identifying the microorganisms implicated 
in deep periprosthetic infection, it is vital to establish their 
antimicrobial resistance and susceptibility patterns to guide 
both prophylactic and therapeutic antibiotic therapies. Such 
therapies include systemic antibiotics (in oral and intrave-
nous form) and local antibiotic delivery via antibiotic-loaded 
bone cement (ALBC) that allows delivery of high concen-
trations of antibiotics to the surgical site while reducing 
systemic side effects. However, while the use of ALBC is 
widespread, there is evidence to suggest that its use may lead 
to resistant bacterial strains [3, 15, 18].
Using data from the National Joint Registry for England 
and Wales and Public Health England, this study therefore 
aimed to: (1) report the rates of resistance against a variety 
of antibiotics for pure Staphylococcal infections, and (2) 
examine the impact of ALBC use on resistance patterns for 
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patients undergoing first-time revision of primary hip and 
knee replacement for indication of infection.
Patients and methods
This retrospective study linked two national databases to 
study antimicrobial susceptibility and resistance patterns in 
first-time revision for Staphylococcal deep periprosthetic 
infection. The methodology used to identify cases revised 
for periprosthetic joint infection (PJI) from the National Joint 
Registry for England, Wales and Northern Ireland (NJR) 
and subsequent linkages to microbiological data from Pub-
lic Health England (PHE) has been described previously 
[11–13]. From the linked cohort of 579 cases (248 hips, 
331 knees) a total of 258 (45%) infected arthroplasties (105 
hips, 153 knees) were identified with a pure Staphylococcal 
periprosthetic infection for whom antimicrobial susceptibili-
ties were available (see Fig. 1). 157 of the cohort were male 
(61%) with a mean age of 68.3 years (range 18–98 years). 
The majority of patients were ASA grade 2 or below (ASA 
1, n = 31, 12%; ASA 2, n = 176, 68%).
Dataset preparation
Diagnosis of periprosthetic infection was determined based 
upon the ‘reason for revision’ indication recorded by the 
surgeon contemporaneously at the time of surgery and sub-
sequently uploaded to the NJR. The recording of a case as 
infected is therefore based upon preoperative clinical review, 
relevant biochemical testing and preoperative microbio-
logical investigation, as well as any perioperative surgical 
findings.
Antimicrobial susceptibility analysis
The study cohort of 258 cases contained more than 3,000 
antimicrobial susceptibility tests. Staphylococcal suscepti-
bility tests against each antimicrobial were classified as ‘sen-
sitive’, ‘intermediate’, or ‘resistant.’ ‘Intermediate’ results 
comprise < 0.5% of results and were therefore excluded. For 
some patients, there were multiple tests against the same 
antimicrobial (e.g.,0020due to multiple samples sent at 
revision surgery); in such cases, where any test result was 
‘resistant’ that patient’s infection was deemed resistant to 
the given antimicrobial (even if other samples were reported 
as ‘sensitive’).
Using the NJR data, cases were classified according to 
the use of bone cement. We defined any use of bone cement 
at primary surgery (including hybrid combinations) as 
cemented fixation. Cement types were further sub-classified 
according to their antibiotic content.
Statistical analysis
The null hypothesis was that, for a range of antimicrobi-
als, the use of gentamicin-loaded bone cement at primary 
surgery would not affect Staphylococcal antimicrobial sus-
ceptibility pattern observed at time of revision. In total 31 
individual antibiotics were tested against the identified sam-
ples. For the purpose of analysis we wanted to identify a 
group of antimicrobials for which we could analyse the influ-
ence of ABLC upon subsequent organism resistance. This 
was done based on the following criteria (a) antimicrobials 
with a minimum number of 100 antimicrobial susceptibility 
tests and (b) tests in which the observed proportion of resist-
ant cases was > 10%. These values were chosen to allow 
meaningful numbers and group sizes within our regression 
analysis. Preliminary analysis demonstrated that the cohort 
of knee arthroplasties was cemented in more than 95% of 
cases. The comparison group (uncemented) was therefore 
too small to allow robust regression analysis. As such, only 
hip arthroplasties were included in the regression analysis.
For each antimicrobial, a binary logistic regression model 
was created with resistance as the outcome and predic-
tors being (1) the use of gentamicin-loaded bone cement 
vs. uncemented fixation; (2) age (grouped by < 55, 55–65, 
65–75, > 75 years); (2) ASA grade (ASA 1, ASA 2, ASA 
3 or 4); (3) gender; (4) body mass index (grouped by < 25, 
25–30, 30–40, > 40 kg/m2) and (5) indication for primary 
surgery. Both univariate and multivariate models were per-
formed. A p value of < 0.05 was deemed to be statistically 
significant.
Ethical approval and data governance
Data for this study were accessed using the standard NJR 
research process. The research request for this study (I.D. 
no. D2072003) was approved by the NJR research com-
mittee on 1 May 2014. Data linkage was achieved directly 
between the NJR and Public Health England. As such, no 
patient sensitive information (NHS no.) was held by New-
castle University as part of this analysis. After methodo-
logical review by Public Health England’s confidentiality 
advisory group, it was determined that ethical approval 
was not required and the project was therefore undertaken Fig. 1  Description of the study cohort
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as a service evaluation. The authors declare that they have 
no conflict of interest with respect to this study which 
received no funding.
Results
Susceptibility profiles for each antimicrobial tested are 
shown in Table 1 for the cohort of 258 arthroplasties. Not 
all antimicrobials were tested for in all cases. Resistance 
rates varied from 0% to more than 96%.
Impact of gentamicin‑loaded bone cement
Staphylococcal resistance patterns for antimicrobials fulfill-
ing the inclusion criteria (ciprofloxacin, clindamycin, eryth-
romycin, fusidic acid, gentamicin, methicillin, penicillin, 
tetracycline and trimethoprim) were compared according to 
the use of either gentamicin-loaded bone cement or unce-
mented fixation at primary hip arthroplasty. For the majority 
of antimicrobials tested, an increased rate of resistance was 
observed in association with the use of gentamicin-loaded 
bone cement. This was most evident for gentamicin where 
the use of gentamicin-loaded bone cement was associated 
with gentamicin resistance in 59 of 166 cases (36%) as com-
pared to 6 of 49 cases (12%) where purely uncemented fixa-
tion was employed at the primary procedure (Tables 2, 3).
For the cohort of infected hip arthroplasties, univariate 
binary logistic regression analysis demonstrated that the 
use of gentamicin-loaded bone cement at primary surgery 
was associated with significantly increased risk of resistance 
at revision surgery to erythromycin (odds ratio 2.73, 95% 
CI 1.062–7.289, p = 0.037), gentamicin (odds ratio 5.278, 
95% CI 1.855–15.017, p = 0.002) and methicillin (odds ratio 
3.252, 95% CI 1.301–8.127, p = 0.012). After adjusting for 
patient and surgical factors, multivariate analysis showed 
the use of gentamicin-loaded bone cement was associated 
with an eightfold increase in the risk of gentamicin resist-
ance (odds ratio 8.341, 95% CI 2.297–30.292, p = 0.001) and 
almost four times the risk of methicillin resistance at revi-
sion for infection (odds ratio 3.870, 95% CI 1.319–11.359, 
p = 0.014). The use of antibiotic-loaded bone cement had no 
significant effect on the rates of Staphylococcal resistance 
to penicillin, fusidic acid, tetracycline, ciprofloxacin, eryth-
romycin, trimethoprim or clindamycin at revision surgery 
when compared to uncemented fixation (Table 4).
Discussion
The principal finding of this study was that for patients 
undergoing revision of a primary hip arthroplasty due to 
Staphylococcal deep infection, there was a significantly 
increased rate of resistance to gentamicin and methicillin 
in association with use of gentamicin-loaded bone cement 
at primary surgery. This study did not identify any further 
significant patient or surgical predictors of Staphylococcal 
antibiotic resistance. Clinicians should be suspicious of gen-
tamicin resistance in all cases where antibiotic-loaded bone 
cement is used at primary surgery and furthermore, in such 
cases, use of gentamicin-loaded cement may not be appro-
priate as a single local antibiotic therapy at revision surgery.
There is strong registry and randomised controlled 
trial evidence for the efficacy of ALBC in reducing the 
rate of both septic and aseptic revision hip and knee 
Table 1  Antimicrobial resistance patterns for cohort of hip and knee 
arthroplasties revised for Staphylococcal infection (n = 258)
Asterix indicates antibiotics tested in regression analysis (> 10% 
resistance, > 100 cases)
Antibiotic No. of cases No. resistant % resistant
Amikacin 13 2 15.4
Amoxycillin/clavulanate 25 10 40.0
Ampicillin_amoxycillin 27 26 96.3
Ceftriaxone 5 4 80.0
Cephalexin 11 4 36.4
Chloramphenicol 103 0 0.0
*Ciprofloxacin 231 71 30.7
Clarithromycin 56 21 37.5
*Clindamycin 163 36 22.1
Co-trimoxazole 39 7 17.9
Daptomycin 51 3 5.9
*Erythromycin 227 80 35.2
Fosfomycin 21 3 14.3
*Fusidic acid 249 83 33.3
*Gentamicin 251 74 29.5
Imipenem 5 4 80.0
Levofloxacin 16 3 18.8
Linezolid 208 1 0.5
*Methicillin 253 100 39.5
Minocycline 1 0 0.0
Moxifloxacin 4 0 0.0
Mupirocin 206 20 9.7
Nitrofurantoin 29 1 3.4
*Penicillin 182 155 85.2
Rifampicin 239 23 9.6
Teicoplanin 173 16 9.2
*Tetracycline 246 44 17.9
Tigecycline 66 0 0.0
Tobramycin 31 12 38.7
*Trimethoprim 180 63 35.0
Vancomycin 208 3 1.4
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arthroplasty [5, 8]. A meta-analysis by Parvizi et al. [20] 
reported that the use of antibiotic-impregnated cement 
lowered periprosthetic infection rate by approximately 
50% in primary hip arthroplasty and for revisions of pre-
viously infected hips, combinations or culture-dependent 
antibiotics lowered infection rates by approximately 40%. 
Although there is an expanding body of work that demon-
strates an increased rate of antibiotic resistance following 
the use of antibiotic-loaded bone cement, this is at odds 
to other studies which refute a significant relationship [7]. 
Hansen et al. [10] found no significant change in the epi-
demiology of infecting pathogens nor any notable increase 
in percentage resistance among organisms isolated from 
patients with deep infection that had received prophylac-
tic antibiotic-loaded cement in their primary joint arthro-
plasty. Whether the benefit of antibiotic-loaded cement 
in managing and preventing deep periprosthetic infection 
outweighs any negative effects from subsequent resistance 
is unknown. However, as microorganism prevalence and 
resistance patterns evolve there may be a need for a greater 
emphasis on the choice of antibiotic used within ALBC.
Previous animal research has demonstrated an increase 
in gentamicin-resistant infections in rats impregnated with 
gentamicin-loaded cement pellets [25].
Antimicrobial resistance can occur in a variety of ways 
[17]. Mutational resistance can occur with various antibi-
otic-organism combinations. Translocation of resistance 
genes to mobile DNA is rarer, but can cause ‘strain epidem-
ics’. Furthermore, existing clones of resistant bacteria may 
simply be selected out in an antibiotic-rich environment. The 
process by which an antibiotic is rendered ineffective against 
a particular bacterial strain may also be related to the use 
of orthopaedic biomaterials as well as the ALBC [1, 2, 9]. 
ALBC has an optimum surface for colonisation, and pro-
longed exposure to antibiotics at sub-inhibitory levels allows 
mutational resistance to occur [15, 16, 19, 22, 25]. In vivo 
cement use (where antibiotic-loaded bone cement will 
remain in situ for many years), is associated with continued 
elution of sub-therapeutic levels of antibiotic for many years 
and this may further increase microbial resistance rates in 
these cases [4, 21, 23].
Corona et al. examined the impact of aminoglycoside-
cement spacers on aminoglycoside resistance in a cohort of 
113 chronic periprosthetic infections following hip and knee 
arthroplasty due to Gram-positive cocci [6]. They reported 
overall gentamicin and tobramycin resistance to be 32 and 
41%, respectively. Additionally they found gentamicin and 
tobramycin resistance at re-revision to be significantly 
higher following the use of aminoglycoside loaded cement 
spacers.
In the univariate analysis, erythromycin resistance was 
significantly higher in patients in the ALBC group. How-
ever, after controlling for other covariates (age, gender, ASA 
grade, BMI, and primary surgery) the effect of ALBC as 
a predictor of erythromycin resistance was no longer sig-
nificant. This can be attributed to the small predictive effect 
of ALBC of erythromycin as evidenced by the 95% confi-
dence intervals in the univariate analysis (Table 4) becom-
ing overwhelmed by the effects of other covariates. The 
methodological and data linkage limitations associated with 
the present study have been discussed previously [11, 12]. 
Unfortunately, the small numbers of cases employing unce-
mented fixation in the knee arthroplasty cohort precluded 
meaningful regression analysis of predictors of antibiotic 
resistance in this group. Antimicrobial susceptibility data 
were missing for 80 of 338 (24%) of cases of Staphylococ-
cal PJI. Antimicrobial susceptibility data submission is not 
mandatory for individual laboratories and whilst we cannot 
rule out selection bias, we believe the risk of this to be low 
as data submission to PHE is not conditional on the particu-
lar antimicrobial susceptibility profile for a given sample.
Notwithstanding the above limitations, the findings of 
our study are supported by existing clinical studies. Weber 
and Lautenbach identified gentamicin resistance in 29% 
of bacteria isolated preoperatively in patients revised for 
periprosthetic infection; this rose to 40% in cases where 
Table 4  Binary logistic 
regression analysis showing 
odds ratio for resistance to 
the named antibiotic given 
the use of gentamicin-loaded 
bone cement compared to 
uncemented fixation at primary 
HIP surgery
*p < 0.05, **p < 0.01
Antibiotic Univariate Multivariate
Odds ratio 95% CI p value Odds ratio 95% CI p value
Ciprofloxacin 2.396 0.900–6.376 0.08 1.901 0.625–5.779 0.258
Clindamycin 2.333 0.392–13.875 0.352 0.573 0.022–14.767 0.737
Erythromycin 2.783 1.062–7.289 0.037* 2.329 0.795–6.826 0.123
Fusidic acid 0.954 0.376–2.421 0.921 0.974 0.333–2.847 0.961
Gentamicin 5.278 1.855–15.017 0.002** 8.341 2.297–30.292 0.001**
Methicillin 3.252 1.301–8.127 0.012* 3.87 1.319–11.359 0.014*
Penicillin 1.015 0.247–4.166 0.983 0.715 0.115–4.467 0.72
Tetracycline 1.783 0.533–5.961 0.348 2.476 0.624–9.832 0.198
Trimethoprim 1.845 0.615–5.535 0.275 2.682 0.729–9.872 0.138
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gentamicin-loaded bone cement was used. In a cohort of 
91 cases, Hope et al. [14] found bacterial strains resistant 
to gentamicin in 88% of cases of prosthetic infection in 
primary hip arthroplasty where cement was loaded with 
this antibiotic as compared to 16% found after those where 
other cement types were used. An increased re-infection 
rate was also seen in patients presenting with a gen-
tamicin-resistant infection. Whilst they did not study the 
impact of antibiotic bone cement, Stefansdottir et al. [24] 
performed a comprehensive analysis of 426 knee arthro-
plasties revised for infection using data from the Swedish 
arthroplasty register. Although antimicrobial susceptibility 
data were incomplete, the study identified a gentamicin 
resistance rate of approximately 34% (20 of 58 cases of 
Staphylococcal infection) which compares favourably to 
an incidence of 29.5% (74 of 251 cases) observed in our 
study. They also reported an increase in the rate of methi-
cillin resistance over time.
In this study we were unable to report microorganism 
at the species level, thus there may be cases of methicillin-
resistant Staphylococcus aureus (MRSA) PJI responsible 
for several of the observed cases of methicillin resistance. 
Furthermore, a significant proportion of Staphylococ-
cal infections will be represented by Coagulase-negative 
staphylococci (CoNS) of which a proportion will be methi-
cillin resistant and hence cross resistance with gentamicin 
and erythromycin is not unexpected; it is possible that gen-
tamicin ALBC may lead to a selection bias for CoNS and 
hence the observed increase in the proportion of resistant 
cases may be due to an organisms’ selection bias rather 
than development of de novo resistance within infecting 
organism.
In conclusion, our study reported the resistance patterns 
of Staphylococci strains to a broad range of antibiotics and 
examined the impact of gentamicin-loaded bone cement 
on the resultant antimicrobial susceptibility profile. Multi-
variate analysis showed the use of gentamicin-loaded bone 
cement was associated with an eightfold increase in the risk 
of gentamicin resistance and almost four times the risk of 
methicillin resistance at revision for infection. Clinicians 
must therefore remain vigilant to the possibility of antibi-
otic resistance to a given ALBC utilised at primary surgery 
when deciding both local and systemic antibiotic choice in 
the treatment of PJI at time of presentation and during revi-
sion surgery.
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